Eterna Therapeutics Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eterna Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Eterna Therapeutics Inc. Return On Assets for the quarter ending June 30, 2024 was -48.4 %, a 41.3% increase year-over-year.
  • Eterna Therapeutics Inc. annual Return On Assets for 2023 was -53 %, a 43.1% increase from 2022.
  • Eterna Therapeutics Inc. annual Return On Assets for 2022 was -93.2 %, a 70.3% increase from 2021.
  • Eterna Therapeutics Inc. annual Return On Assets for 2021 was -314 %, a 285% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -53 +40.2 +43.1% Jan 1, 2023 Dec 31, 2023
2022 -93.2 +220 +70.3% Jan 1, 2022 Dec 31, 2022
2021 -314 -232 -285% Jan 1, 2021 Dec 31, 2021
2020 -81.6 -68.2 -509% Jan 1, 2020 Dec 31, 2020
2019 -13.4 -11.7 -707% Jan 1, 2019 Dec 31, 2019
2018 -1.66 +4.48 +73% Jan 1, 2018 Dec 31, 2018
2017 -6.14 +12.6 +67.3% Jan 1, 2017 Dec 31, 2017
2016 -18.8 +21.9 +53.9% Jan 1, 2016 Dec 31, 2016
2015 -40.7 -16.4 -67.6% Jan 1, 2015 Dec 31, 2015
2014 -24.3 -15.9 -190% Jan 1, 2014 Dec 31, 2014
2013 -8.37 -0.52 -6.62% Jan 1, 2013 Dec 31, 2013
2012 -7.86 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.